Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors

INTRODUCTION. Marburg and Ebola viruses cause severe haemorrhagic fever in humans and primates. Currently, there are no licensed prophylactic vaccines that can simultaneously prevent the spread or reduce the severity of both diseases caused by these filoviruses. The development of effective prophyla...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	T. A. Ozharovskaia, O. V. Zubkova, O. Popova, A. V. Kovyrshina, P. P. Goldovskaya, I. V. Vavilova, I. V. Dolzhikova, E. I. Ermolova, M. S. Kunda, N. N. Ryzhova, O. L. Voronina, D. N. Shcherbinin, D. V. Shcheblyakov, D. Y. Logunov, A. L. Gintsburg
Format:	Artigo
Sprog:	Russo
Udgivet:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-10-01
Serier:	Биопрепараты: Профилактика, диагностика, лечение
Fag:	immunogenicity glycoprotein gene variants ebola virus marburg virus human adenovirus type 5 recombinant adenoviral vectors ebola virus disease marburg virus disease humoral immune response
Online adgang:	https://www.biopreparations.ru/jour/article/view/576
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!